23andMe independent board resigns in feud over CEO Anne Wojcicki’s plan to take company private
All seven of 23andMe’s independent board members resigned in a stinging rebuke to a proposal by CEO Anne Wojcicki’s plans to to take the company private. Wojcicki, who has been trying to take the company private since April, proposed to acquire all outstanding shares of 23andMe not owned by her or her affiliates for $0.40 per share, in July.
Me's entire board of directors resigned over cofounder and CEO Anne Wojcicki's ongoing plan to take it private.
The board of Anne Wojcicki's genetic-testing company resigned earlier this week. This founder thinks he has a plan to save ...
Good morning, Broadsheet readers! All board members resigned from Anne Wojcicki’s 23andMe, Teresa Ribera will likely become Europe’s new antitrust chief, and Midi Health raises $5 million from a ...
By letter dated August 2, 2024, a Special Committee of the Board of Directors of 23andMe rejected that offer, noting that it "provide [d] no premium to the closing price per share on Wednesday, July ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback